MAPK15 mediates the activation of autophagy through starvation, and may be a novel target for small molecule drugs with therapeutic effects in chronic myeloid leukemia [62]. This evidence concerns the gene MAPK15 and chronic myelogenous leukemia, BCR-ABL1 positive.